Inventor · disambiguated record
Laura Brandolini
Also filed as: BRANDOLINI LAURA
11 granted patents·12 pending applications·59 citations·filing 1999–2025
86Inventor score
Top patents by PatentIndex Score
23 records- 0176US8906946B2TRPM8 receptor antagonistsMORICONI ALESSIO·Filed 2012·Granted Dec 9, 2014·6 cites·16 claims
- 0274US6069172A(R)-2-(3-benzoylphenyl) propionic acid salts and pharmaceutical preparations containing themDOMPE SPA·Filed 1999·Granted May 30, 2000·44 cites·24 claims
- 0374US2025032461A1Il-8 inihibitors for use in the treatment of some urological disordersDOMPE FARM SPA·Filed 2024·Application pending·0 cites
- 0472US9856246B2TRPM8 antagonistsDOMPÉ FARM S P A·Filed 2017·Granted Jan 2, 2018·3 cites·2 claims
- 0571US9585875B2TRPM8 antagonistsDOMPÉ S P A·Filed 2012·Granted Mar 7, 2017·3 cites·11 claims
- 0671US2024398731A1C5ar inhibitors for use in the treatment of chemotherapy-induced iatrogenic painDOMPE FARM SPA·Filed 2024·Application pending·0 cites
- 0769US12268671B2IL-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathyDOMPE FARM SPA·Filed 2017·Granted Apr 8, 2025·1 cites·16 claims
- 0868US12133843B2IL-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infectionsDOMPE FARM SPA·Filed 2018·Granted Nov 5, 2024·1 cites·6 claims
- 0966US11660291B2IL-8 inhibitors for use in the treatment of some sarcomasDOMPE FARM SPA·Filed 2018·Granted May 30, 2023·1 cites·19 claims
- 1066US2025009719A1Il-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infectionsDOMPE FARM SPA·Filed 2024·Application pending·0 cites
- 1163US2023248704A1Il-8 inhibitors for use in the treatment of some sarcomasDOMPE FARM SPA·Filed 2023·Application pending·0 cites
- 1259US12102607B2C5aR inhibitors for use in the treatment of chemotherapy-induced iatrogenic painDOMPE FARM SPA·Filed 2018·Granted Oct 1, 2024·0 cites·11 claims
- 1358US2025195479A1Il-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathyDOMPE FARM SPA·Filed 2025·Application pending·0 cites
- 1457US12150933B2IL-8 inihibitors for use in the treatment of some urological disordersDOMPE FARM SPA·Filed 2016·Granted Nov 26, 2024·0 cites·17 claims
- 1556US2025025435A1Co-crystals of nonsteroidal anti-inflammatory drugs, lysine and gabapentin, pharmaceutical compositions and their medical useDOMPE FARM SPA·Filed 2022·Application pending·0 cites
- 1655US2024180888A1C5ar1 inhibitors for treating hypersensitivity reactions to taxanesDOMPE FARM SPA·Filed 2022·Application pending·0 cites
- 1754US2024156757A1Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of seizuresDOMPE FARM SPA·Filed 2022·Application pending·0 cites
- 1850US2025304638A1Nerve growth factor and methods of use thereof for neurodevelopmental disabilities associated with neonatal hypoxic-ischemic encephalopathyDOMPE FARM SPA·Filed 2025·Application pending·0 cites
- 1950US2023165820A1Synergistic admixtures of gabapentin and ketoprofen, pharmaceutical compositions and their medical useDOMPE FARM SPA·Filed 2021·Application pending·0 cites
- 2049US11046662B22-aryl-4-hydroxy-1,3-thiazole derivatives useful as TRPM8-inhibitors in treatment of neuralgia, pain, COPD and asthmaDOMPE FARM SPA·Filed 2018·Granted Jun 29, 2021·0 cites·3 claims
- 2147US2023108050A1Cxcl8 (interleukin-8) activity inhibitor and corticosteroid combination and pharmaceutical composition and use thereofDOMPE FARM SPA·Filed 2021·Application pending·0 cites
- 2244US10196368B22-aryl-4-hydroxy-1,3-thiazole derivatives useful as TRPM8-inhibitors in treatment of neuralgia, pain, COPD and asthmaDOMPE FARM SPA·Filed 2015·Granted Feb 5, 2019·0 cites·18 claims
- 2340US2019336484A1Il-8 inhibitors for use in the treatment of some urological disordersDOMPE FARM SPA·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laura Brandolini files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →